TY - JOUR
T1 - Left Ventricular Diastolic Indices and Their Impact on Outcomes in Patients with Recently Diagnosed Atrial Fibrillation
AU - Ikemura, Nobuhiro
AU - Nakanishi, Koki
AU - Spertus, John A.
AU - Lam, Carolyn S.P.
AU - Kimura, Takehiro
AU - Katsumata, Yoshinori
AU - Fujisawa, Taishi
AU - Ueda, Ikuko
AU - Ohki, Takahiro
AU - Fukuda, Keiichi
AU - Takatsuki, Seiji
AU - Kohsaka, Shun
N1 - Funding Information:
Ikemura received research grants from Bristol-Myers Squibb. Spertus received personal fees from Novartis, AstraZeneca, Janssen, Bayer, Boehringer Ingelheim, Regeneron, Corvia, and United Healthcare; received grants from Bayer and Abbott Vascular. Dr Spertus has a patent copyright to Seattle Angina Questionnaire with royalties paid. Kimura received grants from Bayer Yakuhin, Ltd. Takatsuki received grants from Bayer Pharmaceuticals and Japan Lifeline, received personal fees from Daiichi Sankyo, Bayer Pharmaceuticals, Bristol-Myers Squibb, Abbott, Medtronic, and Boston Scientific. Kohsaka received an unrestricted research grant for the Department of Cardiology at Keio University School of Medicine from Navoartis and Bayer Yakuhin, Ltd.; and received personal fees from Bristol-Myers Squibb and Pfizer. The other authors report no conflict of interest.
Funding Information:
This study was funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant nos. 20H03915, 20J01755, 21K16069).
Publisher Copyright:
© 2022 by the authors.
PY - 2022/10
Y1 - 2022/10
N2 - Background: Early identification of atrial fibrillation (AF) patients at risk for heart failure (HF) remains critical for improving their outcomes. We aimed to investigate whether indices of left ventricular diastolic dysfunction (LVDD) can stratify AF patients without clinical history of HF. Methods: We extracted 1775 patients’ data from a prospective cohort that consecutively recruited recently recognized AF patients with ejection fraction ≥50%. We categorized patients as LVDD grade 0 (none) to 3 (severe) based on mitral deceleration time and E/e’ per the American Society of Echocardiography recommendation. The primary outcome was a composite of all-cause death, stroke, and HF hospitalization during the 2-year follow-up. We also investigated the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) scores. Results: Overall, 857 (48.3%) had mild or higher LVDD. Incidence of primary outcomes increased in parallel with LVDD grading (1.8%, 2.8%, 6.5%, and 8.1% for grades 0–3, respectively, p < 0.001), and the presence of grade 3 LVDD was an independent predictor of the primary outcome (adjusted HR 2.28 (vs. grade 0), 95%CI 1.13–4.60). Furthermore, patients with LVDD had lower AFEQT scores at the enrollment and 1-year follow-up. Conclusions: LVDD indices were associated with adverse clinical outcomes and patients’ perceived health status in a recently diagnosed AF cohort without HF.
AB - Background: Early identification of atrial fibrillation (AF) patients at risk for heart failure (HF) remains critical for improving their outcomes. We aimed to investigate whether indices of left ventricular diastolic dysfunction (LVDD) can stratify AF patients without clinical history of HF. Methods: We extracted 1775 patients’ data from a prospective cohort that consecutively recruited recently recognized AF patients with ejection fraction ≥50%. We categorized patients as LVDD grade 0 (none) to 3 (severe) based on mitral deceleration time and E/e’ per the American Society of Echocardiography recommendation. The primary outcome was a composite of all-cause death, stroke, and HF hospitalization during the 2-year follow-up. We also investigated the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) scores. Results: Overall, 857 (48.3%) had mild or higher LVDD. Incidence of primary outcomes increased in parallel with LVDD grading (1.8%, 2.8%, 6.5%, and 8.1% for grades 0–3, respectively, p < 0.001), and the presence of grade 3 LVDD was an independent predictor of the primary outcome (adjusted HR 2.28 (vs. grade 0), 95%CI 1.13–4.60). Furthermore, patients with LVDD had lower AFEQT scores at the enrollment and 1-year follow-up. Conclusions: LVDD indices were associated with adverse clinical outcomes and patients’ perceived health status in a recently diagnosed AF cohort without HF.
KW - atrial fibrillation
KW - diastolic dysfunction
KW - heart failure
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85139936909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139936909&partnerID=8YFLogxK
U2 - 10.3390/jcm11195732
DO - 10.3390/jcm11195732
M3 - Article
AN - SCOPUS:85139936909
VL - 11
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
SN - 2077-0383
IS - 19
M1 - 5732
ER -